エンタープライズイメージングIT市場 – 2030年までの世界予測

• このレポートでは、機能、モダリティ、アプリケーション、提供内容、展開モード、治療領域、エンドユーザー、地域に基づいて、エンタープライズ イメージング IT 市場を調査します。
• このレポートでは、市場の成長に影響を与える要因（推進要因、制約、機会、課題など）を分析します。
• このレポートでは、利害関係者にとっての市場の機会と課題を評価し、市場リーダーの競争環境の詳細を提供します。
• このレポートでは、マイクロマーケットの成長傾向、見通し、エンタープライズ イメージング IT 市場全体への貢献について調査します。
• このレポートでは、5つの主要地域に関して市場セグメントの収益を予測しています。

本レポートは、既存企業だけでなく新規参入企業や小規模企業にとっても、市場の動向を把握し、シェア拡大に繋げる上で役立ちます。本レポートをご購入いただいた企業は、以下の5つの戦略のいずれか、または組み合わせて活用することができます。

世界のエンタープライズイメージングIT市場は、2025年の23億1,000万米ドルから2030年には41億2,000万米ドルに達し、予測期間中の年平均成長率（CAGR）は12.2%と予測されています。需要を押し上げる要因としては、資本負担の大きいライセンスモデルからクラウドネイティブSaaSへの移行が挙げられます。クラウドネイティブSaaSは、初期費用の削減とアップグレードの迅速化を実現します。ブロックチェーン基盤の画像来歴プラットフォームの登場は、マルチベンダーエコシステム全体のデータ整合性と監査可能性を向上させています。医療ツーリズムネットワークの拡大は、標準化された国境を越えた画像交換ハブの必要性を高めています。また、ポイントオブケア超音波診断装置やウェアラブル画像診断装置の普及は、企業のワークフローをリアルタイムのベッドサイドでの取得へと拡大させています。

The global enterprise imaging IT market is projected to reach USD 4.12 billion by 2030 from USD 2.31 billion in 2025, at a CAGR of 12.2% during the forecast period. Demand is propelled by the shift from capital-heavy license models to cloud native SaaS deployments, which lower upfront costs and accelerate upgrades. The emergence of blockchain-backed image provenance platforms is enhancing data integrity and auditability across multi-vendor ecosystems. Growing medical tourism networks are driving the need for standardized, cross-border image exchange hubs, while the proliferation of point-of-care ultrasound and wearable imaging devices is expanding enterprise workflows to include real-time, bedside acquisitions.

“The diagnostics segment is the fastest-growing segment in the enterprise imaging IT market within the forecast period.”

Based on applications, the enterprise imaging IT market has been divided into diagnostics, therapeutics, and clinical research. The diagnostics segment accounts for the largest share of the enterprise imaging IT market. This segment’s large share and high growth can be attributed to the nationwide rollout of lung cancer screening programs, which has surged low-dose CT volumes and driven enterprise archive demand. The integration of AI-driven triage engines that automatically flag critical findings such as intracranial hemorrhages or pulmonary emboli has also pushed providers to upgrade diagnostic platforms. Additionally, the rise of quantitative radiomics and texture analysis workflows for oncology and neurology imaging is creating demand for solutions that can store, process, and mine high-dimensional feature sets at scale.

“The cardiology segment is estimated to hold the largest share of the enterprise imaging IT market in 2024, by therapeutic area.”

Based on therapeutic area, the enterprise imaging IT market is segmented into neurology, cardiology, oncology, orthopedics, and other therapeutic areas. The cardiology segment held the largest share in 2024 due to the surge in CT-derived fractional flow reserve (FFR CT) workflows, which require seamless integration of computational models and high-fidelity CT archives. The rapid expansion of hybrid cath lab/OR suites is driving the demand for enterprise viewers that can overlay 3D vessel reconstructions in real time during transcatheter valve and structural interventions. New CPT codes for AI-quantified ejection fraction and chamber volumetrics are also incentivizing hospitals to deploy platforms with built-in cardiac analytics. Additionally, the proliferation of wearable ECG and implantable device data streams is pushing cardiology departments to adopt enterprise solutions that fuse multi source signals with imaging studies for comprehensive cardiac risk stratification.

“The Asia Pacific region is expected to register the highest growth rate in the enterprise imaging IT market during the forecast period.”

The global enterprise imaging IT market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2024, Asia Pacific is expected to register the highest growth for enterprise imaging IT in the forecast period. Factors such as India’s National Digital Health Mission integrating imaging data into its Health Locker for unified patient records, the rise of medical tourism hubs in Malaysia and Thailand demanding seamless cross border image exchange, public–private partnerships deploying mobile CT and MRI units in rural China, and the explosive uptake of low cost, AI powered handheld ultrasound devices in South Korea and India are all fueling Asia Pacific’s rapid enterprise imaging IT adoption.

The breakdown of primary participants is as mentioned below:

• By Company Type: Tier 1 (41%), Tier 2 (31%), and Tier 3 (28%)
• By Designation: C-level Executives (44%), Directors (31%), and Others (25%)
• By Region: North America (45%), Europe (28%), Asia Pacific (20%), Latin America (4%), and the Middle East & Africa (3%)

Key Players

The prominent players in this market are Agfa-Gevaert Group (Belgium), FUJIFILM Corporation (Japan), Merative (US), Pro Medicus, Ltd. (Australia), Optum, Inc. (US), GE HealthCare (US), Intelerad (Canada), Sectra AB (Sweden), CANON MEDICAL SYSTEMS CORPORATION (Japan), Hyland Software, Inc. (US), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers AG (Germany), INFINITT Healthcare Co., Ltd. (South Korea), Novarad (US), Mach7 Technologies (US), Hermes Medical Solutions (Sweden), Konica Minolta, Inc. (Japan), BridgeHead Software Ltd. (England), Sclmage, Inc. (US), VISUS Health IT GmbH (Germany), Dicom Systems, Inc. (US), PostDICOM (Netherlands), Qaelum (Belgium), AdvaHealth Solutions (Singapore), PaxeraHealth (US), and Rad AI (US). Players adopted organic and inorganic growth strategies such as solution launches, enhancements, and upgrades; collaborations; partnerships; acquisitions; agreements; and expansions to increase their offerings, cater to customers’ unmet needs, increase their profitability, and expand their presence in the global market.

Research Coverage

• The report studies the enterprise imaging IT market based on function, modality, application, offering, deployment mode, therapeutic area, end user, and region.
• The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.
• The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
• The report studies micromarkets with respect to their growth trends, prospects, and contributions to the total enterprise imaging IT market.
• The report forecasts the revenue of market segments with respect to five major regions.

Reasons to Buy the Report

The report can help established firms, as well as new entrants/smaller firms, gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or a combination of the five strategies mentioned below.

This report provides insights into the following pointers:

• Analysis of key drivers, restraints, opportunities, and challenges influencing the growth of the enterprise imaging IT market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the enterprise imaging IT market.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of enterprise imaging IT solutions across regions.
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the enterprise imaging IT market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the enterprise imaging IT market.

Table of Contents

1               INTRODUCTION              33

1.1           STUDY OBJECTIVES       33

1.2           MARKET DEFINITION   33

1.3           MARKET SCOPE                34

1.3.1        MARKET SEGMENTATION & REGIONAL SCOPE 34

1.3.2        INCLUSIONS & EXCLUSIONS       35

1.4           YEARS CONSIDERED      36

1.5           CURRENCY          37

1.6           LIMITATIONS    37

1.7           STAKEHOLDERS               38

2               RESEARCH METHODOLOGY       39

2.1           RESEARCH DATA              39

2.1.1        SECONDARY DATA          40

2.1.1.1    Key data from secondary sources       40

2.1.2        PRIMARY DATA 41

2.1.2.1    Key data from primary sources           42

2.1.2.2    Breakdown of primary sources           43

2.2           RESEARCH APPROACH  44

2.3           MARKET SIZE ESTIMATION         45

2.4           MARKET BREAKDOWN & DATA TRIANGULATION                 52

2.5           RESEARCH ASSUMPTIONS           53

2.5.1        MARKET SIZING ASSUMPTIONS                53

2.5.2        OVERALL STUDY ASSUMPTIONS              53

2.6           RISK ASSESSMENT           54

2.7           RESEARCH LIMITATIONS             54

2.7.1        METHODOLOGY-RELATED LIMITATIONS           54

2.7.2        SCOPE-RELATED LIMITATIONS                 54

3               EXECUTIVE SUMMARY  55

4               PREMIUM INSIGHTS       60

4.1           ENTERPRISE IMAGING IT MARKET OVERVIEW  60

4.2           NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY APPLICATION & REGION       61

4.3           ENTERPRISE IMAGING IT MARKET: GEOGRAPHIC SNAPSHOT          62

4.4           ENTERPRISE IMAGING IT MARKET: DEVELOPED VS. EMERGING ECONOMIES               63

5               MARKET OVERVIEW       64

5.1           INTRODUCTION              64

5.2           MARKET DYNAMICS       64

5.2.1        DRIVERS               66

5.2.1.1    Increased demand for scalable and cost-effective solutions                 66

5.2.1.2    Advancements in Al and imaging technologies                66

5.2.1.3    Growing volume of medical imaging procedures             67

5.2.1.4    Growing need for remote access and collaborative care 67

5.2.1.5    Government initiatives and favorable policies 68

5.2.2        RESTRAINTS      69

5.2.2.1    Data security and privacy concerns   69

5.2.2.2    Lack of skilled professionals for deployment and interpretation                 72

5.2.3        OPPORTUNITIES              73

5.2.3.1    Expansion into emerging markets     73

5.2.3.2    Multi modality and advanced visualization      74

5.2.3.3    Partnerships with AI and analytics providers   74

5.2.3.4    Value-based care and population health management   75

5.2.3.5    Cloud native and edge computing innovations                76

5.2.4        CHALLENGES    76

5.2.4.1    Interoperability with legacy and vendor‑specific systems                 76

5.2.4.2    High upfront integration and deployment costs              76

5.2.4.3    Workflow disruption and user adoption            77

5.3           TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES       77

5.4           INDUSTRY TRENDS         78

5.4.1        AI-ENABLED DIAGNOSTICS AND PREDICTIVE ANALYTICS         78

5.4.2        UNIFIED IMAGING DATA INTEGRATION AND COLLABORATIVE DIAGNOSTICS              79

5.4.3        CLOUD-BASED IMAGING IT PLATFORMS AND DIGITAL TRANSFORMATION        79

5.5           ECOSYSTEM ANALYSIS  80

5.6           SUPPLY CHAIN ANALYSIS             83

5.7           TECHNOLOGY ANALYSIS             85

5.7.1        KEY TECHNOLOGIES     85

5.7.1.1    Imaging analytics platforms                86

5.7.1.2    Artificial intelligence and machine learning     86

5.7.1.3    Multi modality fusion & co registration engines              87

5.7.1.4    Zero footprint viewers         87

5.7.1.5    Mobile enterprise imaging and workflow bots 87

5.7.2        COMPLEMENTARY TECHNOLOGIES       88

5.7.2.1    Radiology information systems (RIS)                88

5.7.2.2    Electronic health record (EHR/EMR) integration          88

5.7.3        ADJACENT TECHNOLOGIES       89

5.7.3.1    Cloud computing & storage                 89

5.7.3.2    Blockchain & distributed ledger technology     89

5.8           REGULATORY ANALYSIS               90

5.8.1        REGULATORY BODIES, GOVERNMENT AGENCIES, & OTHER ORGANIZATIONS             90

5.8.2        REGULATORY LANDSCAPE         94

5.8.2.1    North America      94

5.8.2.2    Europe   95

5.8.2.3    Asia Pacific            96

5.8.2.4    Latin America       97

5.8.2.5    Middle East & Africa            97

5.9           PRICING ANALYSIS          98

5.9.1        INDICATIVE PRICING FOR ENTERPRISE IT IMAGING SOLUTIONS, BY FUNCTION (2024)            99

5.9.2        INDICATIVE PRICING FOR ENTERPRISE IT IMAGING SOLUTIONS, BY REGION (2024)  99

5.10         PORTER’S FIVE FORCES ANALYSIS           100

5.10.1      BARGAINING POWER OF SUPPLIERS       102

5.10.2      BARGAINING POWER OF BUYERS             102

5.10.3      THREAT OF SUBSTITUTES          102

5.10.4      THREAT OF NEW ENTRANTS      102

5.10.5      INTENSITY OF COMPETITIVE RIVALRY 102

5.11         PATENT ANALYSIS          103

5.11.1      PATENT PUBLICATION TRENDS FOR ENTERPRISE IMAGING IT MARKET     103

5.11.2      INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS            104

5.12         KEY STAKEHOLDERS & BUYING CRITERIA            107

5.12.1      KEY STAKEHOLDERS IN BUYING PROCESS           107

5.12.2      BUYING CRITERIA           108

5.13         END-USER ANALYSIS      109

5.13.1      UNMET NEEDS 109

5.13.2      END-USER EXPECTATIONS         110

5.14         KEY CONFERENCES & EVENTS, 2025–2026              111

5.15         CASE STUDY ANALYSIS 112

5.16         INVESTMENT & FUNDING SCENARIO     114

5.17         BUSINESS MODEL ANALYSIS      115

5.18         IMPACT OF GENERATIVE AI ON ENTERPRISE IMAGING IT MARKET         116

5.18.1      TOP USE CASES & MARKET POTENTIAL                 116

5.18.1.1  Key use cases         117

5.18.2      CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION         118

5.18.2.1  Case Study 1: Enabling interoperability and scalability across enterprise imaging networks with Dicom Systems’ Unifier Platform                 118

5.18.2.2  Case Study 2: More images, more insight, more collaboration – San Gerardo Hospital transforms radiology with Agfa HealthCare’s Enterprise Imaging               119

5.18.3      INTERCONNECTED & ADJACENT MARKETS        120

5.18.3.1  Vendor Neutral Archive (VNA) & PACS Market            120

5.18.3.2  Medical Image Analysis Software Market         120

5.18.3.3  Healthcare IT Market          121

5.18.4      USER READINESS & IMPACT ASSESSMENT            121

5.18.4.1  User readiness       121

5.18.4.1.1                User A: Hospitals 121

5.18.4.1.2                User B: Diagnostic centers 121

5.18.4.2  Impact assessment                122

5.18.4.2.1                User A: Hospitals 122

5.18.4.2.1.1            Implementation    122

5.18.4.2.1.2            Impact    122

5.18.4.2.2                User B: Diagnostic centers 122

5.18.4.2.2.1            Implementation    122

5.18.4.2.2.2            Impact    123

5.19         IMPACT OF 2025 US TARIFFS ON ENTERPRISE IMAGING IT MARKET         123

5.19.1      INTRODUCTION              123

5.19.2      KEY TARIFF RATES          124

5.19.3      PRICE IMPACT ANALYSIS             124

5.19.3.1  Increased costs of hardware components          125

5.19.3.2  Software & licensing inflation             125

5.19.3.3  Supply chain disruption       125

5.19.4      IMPACT ON COUNTRY/REGION                125

5.19.4.1  US           125

5.19.4.2  Europe   125

5.19.4.3  Asia Pacific            126

5.19.5      IMPACT ON END USERS                126

5.19.5.1  Hospitals (large, mid-sized, and academic medical centers)                 126

5.19.5.2  Diagnostic centers (independent and chain-based)       126

5.19.5.3  Teleradiology providers       126

6               ENTERPRISE IMAGING IT MARKET, BY FUNCTION                 128

6.1           INTRODUCTION              129

6.2           VENDOR NEUTRAL ARCHIVES (VNA)      129

6.2.1        ADVANCING SEAMLESS INFORMATION EXCHANGE THROUGH VNA SOLUTIONS TO BOOST MARKET GROWTH                 129

6.3           PICTURE ARCHIVING AND COMMUNICATION SYSTEMS (PACS)  131

6.3.1        GROWING INTEGRATION OF AI WITHIN PACS FOR OPTIMIZED RADOIOLOGY WORKFLOWS TO SUPPORT MARKET GROWTH             131

6.4           IMAGE EXCHANGE          132

6.4.1        GROWING POPULARITY OF INTEROPERABLE IMAGING NETWORKS FOR PATIENT-CENTERED DATA SHARING TO DRIVE GROWTH               132

6.5           UNIVERSAL VIEWERS     134

6.5.1        GROWING UNIVERSAL VIEWER DEPLOYMENT FOR MULTI-DISCIPLINARY IMAGING TO FUEL MARKET         134

6.6           WORKFLOW ORCHESTRATION 135

6.6.1        AI-POWERED IMAGING WORKFLOW AUTOMATION AND CROSS-MODALITY COORDINATION TO PROPEL MARKET                 135

6.7           ANALYTICS         137

6.7.1        GROWING NEED FOR ANALYTICS PLATFORMS FOR VALUE-BASED IMAGING AND OPERATIONAL OPTIMIZATION TO DRIVE MARKET         137

6.8           OTHER FUNCTIONS       138

7               ENTERPRISE IMAGING IT MARKET, BY APPLICATION                 140

7.1           INTRODUCTION              141

7.2           DIAGNOSTICS   141

7.2.1        AI-ENABLED QUANTIFICATION AND INTEGRATED THERANOSTIC WORKFLOWS TO DRIVE DIAGNOSTIC IMAGING TRANSFORMATION        141

7.3           THERAPEUTICS                142

7.3.1        ADVANTAGES SUCH AS MULTIMODAL TREATMENT INTEGRATION TO OPTIMIZE ENTERPRISE IMAGING FOR THERAPEUTIC WORKFLOWS      142

7.4           CLINICAL RESEARCH     143

7.4.1        AI-ENABLED QUANTIFICATION AND RAPID-RESPONSE IMAGING WORKFLOWS TO ACCELERATE CLINICAL RESEARCH                 143

8               ENTERPRISE IMAGING IT MARKET, BY MODALITY                 145

8.1           INTRODUCTION              146

8.2           X-RAY    146

8.2.1        GROWTH IN ENTERPRISE IMAGING THROUGH AI-ENABLED X-RAY SOLUTIONS TO BOOST MARKET            146

8.3           MAGNETIC RESONANCE IMAGING (MRI)              148

8.3.1        EXPANDING MRI ENTERPRISE IT TO MEET RISING NEUROLOGICAL IMAGING DEMANDS TO SUPPORT MARKET GROWTH             148

8.4           COMPUTED TOMOGRAPHY (CT)              149

8.4.1        REGULATORY AND VALUE-BASED INCENTIVES TO FUEL CT IMAGING IT ADOPTION             149

8.5           ULTRASOUND  150

8.5.1        AI-POWERED ULTRASOUND AND POCUS TO ACCELERATE ENTERPRISE IMAGING TRANSFORMATION                 150

8.6           NUCLEAR IMAGING        151

8.6.1        POSITRON EMISSION TOMOGRAPHY (PET)        153

8.6.1.1    Rising PET scan volumes to drive demand for scalable, intelligent Imaging IT             153

8.6.2        SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT)                154

8.6.2.1    Driving diagnostic accuracy with automated SPECT workflows to contribute to growth             154

8.7           ENDOSCOPY      155

8.7.1        ENABLING REAL-TIME ENDOSCOPIC INSIGHTS THROUGH CLOUD-NATIVE VIDEO ORCHESTRATION TO DRIVE MARKET               155

8.8           MAMMOGRAPHY              156

8.8.1        NEED FOR ENTERPRISE IMAGING SOLUTIONS FOR HIGH-VOLUME, HIGH-RESOLUTION MAMMOGRAPHY WORKFLOWS TO FUEL GROWTH              156

8.9           FLUOROSCOPY 157

8.9.1        STRATEGIC CLOUD-NATIVE IMAGING FOR ADVANCED FLUOROSCOPY USE CASES TO AID WITH GROWTH         157

8.10         ECHOCARDIOGRAPHY  158

8.10.1      ABILITY TO ENHANCE FLUOROSCOPY IMAGING EFFICIENCY WITH AI-INTEGRATED ENTERPRISE IT SOLUTIONS TO BOOST MARKET        158

8.11         OTHER MODALITIES     159

9               ENTERPRISE IMAGING IT MARKET, BY OFFERING                 161

9.1           INTRODUCTION              162

9.2           SOFTWARE         162

9.2.1        ADVANCING UNIFIED IMAGING ECOSYSTEMS THROUGH CLOUD-NATIVE SOFTWARE TO BOOST MARKET GROWTH             162

9.3           SERVICES             163

9.3.1        ADVANTAGES SUCH AS EXPERT SERVICES, CLOUD MIGRATION, AND WORKFLOW OPTIMIZATION TO SUPPORT MARKET GROWTH          163

10            ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE   165

10.1         INTRODUCTION              166

10.2         ON-PREMISE SOLUTIONS             166

10.2.1      GROWING NEED FOR IMAGING PERFORMANCE AND DATA CONTROL THROUGH ON-PREMISE DEPLOYMENT TO SUPPORT MARKET GROWTH     166

10.3         CLOUD-BASED SOLUTIONS        167

10.3.1      RISING NEED FOR COST-EFFICIENT, SCALABLE INFRASTRUCTURE TO DRIVE DEMAND FOR CLOUD-BASED DEPLOYMENT  167

10.4         HYBRID SOLUTIONS      168

10.4.1      ABILITY TO BRIDGE DATA CONTROL AND CLOUD INNOVATION THROUGH HYBRID DEPLOYMENT TO BOOST GROWTH             168

11            ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA     170

11.1         INTRODUCTION              171

11.2         NEUROLOGY     171

11.2.1      INTEGRATION OF AI-DRIVEN MULTIMODAL NEUROIMAGING FOR PERSONALIZED NEUROLOGICAL CARE TO BOOST MARKET        171

11.3         CARDIOLOGY    173

11.3.1      CLOUD-ENABLED, AI-DRIVEN ENTERPRISE IMAGING PLATFORMS TO ACCELERATE ADVANCED CARDIAC DIAGNOSTICS   173

11.4         ONCOLOGY        174

11.4.1      AI-DRIVEN, MULTIMODAL ENTERPRISE IMAGING PLATFORMS TO ADVANCE PRECISION ONCOLOGY        174

11.5         ORTHOPEDICS 175

11.5.1      ABILITY OF AI-ENABLED ENTERPRISE IMAGING PLATFORMS TO TRANSFORM ORTHOPEDIC CARE TO DRIVE DEMAND             175

11.6         OTHER THERAPEUTIC AREAS    176

12            ENTERPRISE IMAGING IT MARKET, BY END USER                 177

12.1         INTRODUCTION              178

12.2         HOSPITALS         178

12.2.1      HOSPITALS TO DRIVE DEMAND FOR UNIFIED IMAGING INFRASTRUCTURE TO SUPPORT INTEGRATED CARE DELIVERY                 178

12.3         DIAGNOSTIC CENTERS 180

12.3.1      GROWING ADOPTION OF ENTERPRISE IMAGING IT TO ENHANCE WORKFLOW EFFICIENCY IN DIAGNOSTIC CENTERS TO BOOST MARKET        180

12.4         CLINICS & OUTPATIENT SETTINGS         181

12.4.1      GROWING POPULARITY OF LIGHTWEIGHT ENTERPRISE IMAGING IT TO BOOST EFFICIENCY AND PATIENT THROUGHPUT TO FUEL GROWTH          181

12.5         PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES                 182

12.5.1      GROWING USE OF ENTERPRISE IMAGING IT FOR TRANSLATIONAL RESEARCH AND DRUG DEVELOPMENT TO DRIVE MARKET 182

12.6         MEDTECH COMPANIES 183

12.6.1      ABILITY OF ENTERPRISE IMAGING IT TO ACCELERATE DEVICE INNOVATION AND CLINICAL INTEGRATION TO FUEL ADOPTION         183

12.7         RESEARCH & ACADEMIC INSTITUTES    184

12.7.1      GROWING NEED TO POWER DATA-DRIVEN DISCOVERY AND COLLABORATION TO SUPPORT MARKET GROWTH                 184

12.8         OTHER END USERS         185

13            ENTERPRISE IMAGING IT MARKET, BY REGION 187

13.1         INTRODUCTION              188

13.2         NORTH AMERICA             188

13.2.1      MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 189

13.2.2      US           194

13.2.2.1  AI integration, cloud adoption, and regulatory push to accelerate enterprise imaging IT transformation in US    194

13.2.3      CANADA               199

13.2.3.1  Provincial interoperability mandates and cloud-enabled AI to drive growth in Canada’s imaging IT market   199

13.3         EUROPE               203

13.3.1      MACROECONOMIC OUTLOOK FOR EUROPE      203

13.3.2      GERMANY           208

13.3.2.1  Hospital modernization and ePA adoption to propel Germany’s enterprise imaging IT growth             208

13.3.3      UK          212

13.3.3.1  NHS push for AI-driven imaging and cloud integration to fuel market growth       212

13.3.4      FRANCE                216

13.3.4.1  France to accelerate cloud-native, interoperable imaging platforms with focus on data sovereignty          216

13.3.5      ITALY    220

13.3.5.1  Growing VNA and teleradiology adoption in Italy to modernize imaging infrastructure         220

13.3.6      SPAIN    224

13.3.6.1  Spain to scale cloud imaging and VNA for regional collaboration                 224

13.3.7      REST OF EUROPE             228

13.4         ASIA PACIFIC     232

13.4.1      MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 233

13.4.2      CHINA  239

13.4.2.1  AI diagnostic approvals to accelerate market growth      239

13.4.3      JAPAN   243

13.4.3.1  Aging demographics to drive demand for scalable imaging solutions 243

13.4.4      INDIA    247

13.4.4.1  Government-led digitization to fuel imaging infrastructure expansion               247

13.4.5      REST OF ASIA PACIFIC   251

13.5         LATIN AMERICA                255

13.5.1      MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 255

13.5.2      BRAZIL 260

13.5.2.1  Government investments to accelerate public health digitization drives      260

13.5.3      MEXICO                264

13.5.3.1  Accelerating imaging modernization through nationwide digital integration in Mexico to boost market               264

13.5.4      REST OF LATIN AMERICA             268

13.6         MIDDLE EAST & AFRICA                272

13.6.1      MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 272

13.6.2      GCC COUNTRIES              277

13.6.2.1  Enterprise imaging adoption accelerates across GCC amid workforce gaps and digital health push to support growth             277

13.6.3      REST OF MIDDLE EAST & AFRICA             282

14            COMPETITIVE LANDSCAPE         286

14.1         OVERVIEW          286

14.2         KEY PLAYER STRATEGIES/RIGHT TO WIN            286

14.2.1      OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ENTERPRISE IMAGING IT MARKET    287

14.3         REVENUE ANALYSIS, 2020–2024  290

14.4         MARKET SHARE ANALYSIS, 2024                 291

14.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 293

14.5.1      STARS   293

14.5.2      EMERGING LEADERS     293

14.5.3      PERVASIVE PLAYERS      293

14.5.4      PARTICIPANTS 294

14.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         295

14.5.5.1  Company footprint               295

14.5.5.2  Region footprint   296

14.5.5.3  Function footprint                297

14.5.5.4  Application footprint            298

14.5.5.5  Therapeutic area footprint  299

14.5.5.6  Deployment mode footprint                300

14.6         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        301

14.6.1      PROGRESSIVE COMPANIES         301

14.6.2      RESPONSIVE COMPANIES            301

14.6.3      DYNAMIC COMPANIES  301

14.6.4      STARTING BLOCKS         301

14.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024                 303

14.6.5.1  Detailed list of key startups/SMEs    303

14.6.5.2  Competitive benchmarking of startups/SMEs 303

14.7         COMPANY VALUATION & FINANCIAL METRICS 305

14.7.1      FINANCIAL METRICS      305

14.7.2      COMPANY VALUATION 305

14.8         BRAND/SOFTWARE COMPARISON           306

14.9         COMPETITIVE SCENARIO             307

14.9.1      SOLUTION LAUNCHES, APPROVALS, AND ENHANCEMENTS             307

14.9.2      DEALS  308

14.9.3      EXPANSIONS     309

15            COMPANY PROFILES      310

15.1         KEY PLAYERS     310

15.1.1      AGFA-GEVAERT GROUP                310

15.1.1.1  Business overview 310

15.1.1.2  Solutions offered  311

15.1.1.3  Recent developments           313

15.1.1.3.1                Deals      313

15.1.1.4  MnM view              314

15.1.1.4.1                Key strengths        314

15.1.1.4.2                Strategic choices   314

15.1.1.4.3                Weaknesses & competitive threats     314

15.1.2      FUJIFILM HOLDINGS CORPORATION     315

15.1.2.1  Business overview 315

15.1.2.2  Solutions offered  317

15.1.2.3  Recent developments           318

15.1.2.3.1                Deals      318

15.1.2.4  MnM view              318

15.1.2.4.1                Key strengths        318

15.1.2.4.2                Strategic choices   319

15.1.2.4.3                Weaknesses & competitive threats     319

15.1.3      GE HEALTHCARE             320

15.1.3.1  Business overview 320

15.1.3.2  Solutions offered  321

15.1.3.3  Recent developments           322

15.1.3.3.1                Solution launches & approvals            322

15.1.3.3.2                Deals      323

15.1.3.4  MnM view              324

15.1.3.4.1                Key strengths        324

15.1.3.4.2                Strategic choices   324

15.1.3.4.3                Weaknesses & competitive threats     324

15.1.4      KONINKLIJKE PHILIPS N.V.          325

15.1.4.1  Business overview 325

15.1.4.2  Solutions offered  326

15.1.4.3  Recent developments           328

15.1.4.3.1                Solution launches & approvals            328

15.1.4.3.2                Deals      329

15.1.4.3.3                Expansions             329

15.1.4.4  MnM view              330

15.1.4.4.1                Key strengths        330

15.1.4.4.2                Strategic choices   330

15.1.4.4.3                Weaknesses & competitive threats     330

15.1.5      SIEMENS HEALTHINEERS AG      331

15.1.5.1  Business overview 331

15.1.5.2  Solutions offered  332

15.1.5.3  Recent developments           335

15.1.5.3.1                Solution launches 335

15.1.5.3.2                Deals      335

15.1.5.4  MnM view              335

15.1.5.4.1                Key strengths        335

15.1.5.4.2                Strategic choices   336

15.1.5.4.3                Weaknesses & competitive threats     336

15.1.6      OPTUM, INC.     337

15.1.6.1  Business overview 337

15.1.6.2  Solutions offered  338

15.1.6.3  Recent developments           340

15.1.6.3.1                Deals      340

15.1.6.4  MnM view              340

15.1.6.4.1                Key strengths        340

15.1.6.4.2                Strategic choices   340

15.1.6.4.3                Weaknesses & competitive threats     341

15.1.7      SECTRA AB         342

15.1.7.1  Business overview 342

15.1.7.2  Solutions offered  344

15.1.7.3  Recent developments           346

15.1.7.3.1                Solution launches & approvals            346

15.1.7.3.2                Deals      347

15.1.8      CANON MEDICAL SYSTEMS CORPORATION        348

15.1.8.1  Business overview 348

15.1.8.2  Solutions offered  350

15.1.8.3  Recent developments           351

15.1.8.3.1                Deals      351

15.1.8.3.2                Expansions             351

15.1.9      MERATIVE           352

15.1.9.1  Business overview 352

15.1.9.2  Solutions offered  352

15.1.9.3  Recent developments           353

15.1.9.3.1                Deals      353

15.1.9.3.2                Expansions             353

15.1.10   PRO MEDICUS, LTD.       354

15.1.10.1                 Business overview 354

15.1.10.2                 Solutions offered  356

15.1.10.3                 Recent developments           357

15.1.10.3.1             Solution launches 357

15.1.10.3.2             Deals      357

15.1.11   INTELERAD MEDICAL SYSTEMS INCORPORATED                 358

15.1.11.1                 Business overview 358

15.1.11.2                 Solutions offered  358

15.1.11.3                 Recent developments           360

15.1.11.3.1             Solution launches 360

15.1.11.3.2             Deals      360

15.1.12   HYLAND SOFTWARE, INC.            362

15.1.12.1                 Business overview 362

15.1.12.2                 Solutions offered  362

15.1.12.3                 Recent developments           363

15.1.12.3.1             Solution launches 363

15.1.12.3.2             Deals      363

15.1.13   INFINITT HEALTHCARE CO., LTD.            365

15.1.13.1                 Business overview 365

15.1.13.2                 Solutions offered  366

15.1.13.3                 Recent developments           366

15.1.13.3.1             Solution launches & approvals            366

15.1.13.3.2             Deals      367

15.1.14   NOVARAD           368

15.1.14.1                 Business overview 368

15.1.14.2                 Solutions offered  368

15.1.15   MACH7 TECHNOLOGIES               370

15.1.15.1                 Business overview 370

15.1.15.2                 Solutions offered  372

15.1.15.3                 Recent developments           373

15.1.15.3.1             Solution launches 373

15.1.15.3.2             Deals      373

15.1.16   HERMES MEDICAL SOLUTIONS 374

15.1.16.1                 Business overview 374

15.1.16.2                 Solutions offered  374

15.1.16.3                 Recent developments           376

15.1.16.3.1             Solution launches, approvals, and enhancements                 376

15.1.16.3.2             Deals      377

15.1.17   KONICA MINOLTA, INC.                378

15.1.17.1                 Business overview 378

15.1.17.2                 Solutions offered  379

15.1.17.3                 Recent developments           381

15.1.17.3.1             Solution launches & enhancements   381

15.1.17.3.2             Deals      381

15.1.18   BRIDGEHEAD SOFTWARE LTD. 383

15.1.18.1                 Business overview 383

15.1.18.2                 Solutions offered  383

15.1.18.3                 Recent developments           384

15.1.18.3.1             Deals      384

15.1.19   SCIMAGE, INC.  385

15.1.19.1                 Business overview 385

15.1.19.2                 Solutions offered  385

15.1.19.3                 Recent developments           386

15.1.19.3.1             Solution launches 386

15.1.19.3.2             Deals      387

15.1.20   VISUS HEALTH IT GMBH               388

15.1.20.1                 Business overview 388

15.1.20.2                 Solutions offered  388

15.1.20.3                 Recent developments           389

15.1.20.3.1             Solution enhancements       389

15.2         OTHER PLAYERS              390

15.2.1      DICOM SYSTEMS, INC.   390

15.2.2      POSTDICOM      391

15.2.3      QAELUM              392

15.2.4      ADVAHEALTH SOLUTIONS         393

15.2.5      PAXERAHEALTH               394

15.2.6      RAD AI  395

16            APPENDIX           396

16.1         DISCUSSION GUIDE        396

16.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                402

16.3         CUSTOMIZATION OPTIONS        404

16.4         RELATED REPORTS         405

16.5         AUTHOR DETAILS           406

LIST OF TABLES

TABLE 1                EXCHANGE RATES UTILIZED FOR CONVERSION TO USD                37

TABLE 2                FACTOR ANALYSIS          49

TABLE 3                RISK ASSESSMENT: ENTERPRISE IMAGING IT MARKET               54

TABLE 4                ENTERPRISE IMAGING IT MARKET: IMPACT ANALYSIS            65

TABLE 5                TOP 30 HEALTHCARE DATA BREACHES IN US, 2011–2024              71

TABLE 6                ENTERPRISE IMAGING IT MARKET: ROLE IN ECOSYSTEM       82

TABLE 7                NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  90

TABLE 8                EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  91

TABLE 9                ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  92

TABLE 10              LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  93

TABLE 11              MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  94

TABLE 12              REGULATORY SCENARIO OF NORTH AMERICA                 94

TABLE 13              REGULATORY SCENARIO OF EUROPE    95

TABLE 14              REGULATORY SCENARIO OF ASIA PACIFIC                 96

TABLE 15              REGULATORY SCENARIO OF LATIN AMERICA                 97

TABLE 16              REGULATORY SCENARIO OF MIDDLE EAST & AFRICA 97

TABLE 17              INDICATIVE PRICING FOR ENTERPRISE IT IMAGING SOLUTIONS,

BY FUNCTION (2024)      99

TABLE 18              INDICATIVE PRICING FOR ENTERPRISE IT IMAGING SOLUTIONS, BY REGION (2024)              100

TABLE 19              ENTERPRISE IMAGING IT MARKET: PORTER’S FIVE FORCES ANALYSIS 101

TABLE 20              JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR ENTERPRISE IMAGING IT MARKET       104

TABLE 21              ENTERPRISE IMAGING IT MARKET: LIST OF PATENTS/PATENT APPLICATIONS          106

TABLE 22              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF

TOP THREE END USERS (%)        107

TABLE 23              KEY BUYING CRITERIA FOR TOP THREE END USERS   108

TABLE 24              UNMET NEEDS IN ENTERPRISE IMAGING IT MARKET               109

TABLE 25              END-USER EXPECTATIONS IN ENTERPRISE IMAGING IT MARKET     110

TABLE 26              ENTERPRISE IMAGING IT MARKET: KEY CONFERENCES & EVENTS, 2025–2026       111

TABLE 27              CASE STUDY 1: ENHANCING IMAGING EFFICIENCY & SECURITY WITH SECTRA’S AUTOMATED MULTIMEDIA WORKFLOW          112

TABLE 28              CASE STUDY 2: ENTERPRISE IMAGING CONSOLIDATION AT PIEDMONT HEALTHCARE WITH HYLAND VNA       113

TABLE 29              CASE STUDY 3: ENTERPRISE-WIDE IMAGING UNIFICATION WITH GE’S EDISON DATALOGUE AT A LEADING MEDICAL CENTER           113

TABLE 30              US-ADJUSTED RECIPROCAL TARIFF RATES                 124

TABLE 31              ENTERPRISE IMAGING IT MARKET, BY FUNCTION, 2023–2030 (USD MILLION)   129

TABLE 32              VENDOR NEUTRAL ARCHIVES (VNA) OFFERED BY KEY MARKET PLAYERS            130

TABLE 33              ENTERPRISE IMAGING IT MARKET FOR VENDOR NEUTRAL ARCHIVES (VNA),

BY REGION, 2023–2030 (USD MILLION)   130

TABLE 34              PICTURE ARCHIVING AND COMMUNICATION SYSTEMS (PACS) OFFERED

BY KEY MARKET PLAYERS            132

TABLE 35              ENTERPRISE IMAGING IT MARKET FOR PICTURE ARCHIVING AND COMMUNICATION SYSTEMS (PACS), BY REGION, 2023–2030 (USD MILLION)   132

TABLE 36              IMAGE EXCHANGE SOLUTIONS OFFERED BY KEY MARKET PLAYERS  133

TABLE 37              ENTERPRISE IMAGING IT MARKET FOR IMAGE EXCHANGE, BY REGION,

2023–2030 (USD MILLION)            134

TABLE 38              UNIVERSAL VIEWERS OFFERED BY KEY MARKET PLAYERS              135

TABLE 39              ENTERPRISE IMAGING IT MARKET FOR UNIVERSAL VIEWERS, BY REGION,

2023–2030 (USD MILLION)            135

TABLE 40              WORKFLOW ORCHESTRATION SOLUTIONS OFFERED BY KEY MARKET PLAYERS       136

TABLE 41              ENTERPRISE IMAGING IT MARKET FOR WORKFLOW ORCHESTRATION, BY REGION, 2023–2030 (USD MILLION)            137

TABLE 42              ANALYTICS SOLUTIONS OFFERED BY KEY MARKET PLAYERS           138

TABLE 43              ENTERPRISE IMAGING IT MARKET FOR ANALYTICS, BY REGION,

2023–2030 (USD MILLION)            138

TABLE 44              ENTERPRISE IMAGING IT MARKET FOR OTHER FUNCTIONS, BY REGION,

2023–2030 (USD MILLION)            139

TABLE 45              ENTERPRISE IMAGING IT MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              141

TABLE 46              ENTERPRISE IMAGING IT MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)            142

TABLE 47              ENTERPRISE IMAGING IT MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)            143

TABLE 48              ENTERPRISE IMAGING IT MARKET FOR CLINICAL RESEARCH APPLICATIONS,

BY REGION, 2023–2030 (USD MILLION)   144

TABLE 49              ENTERPRISE IMAGING IT MARKET, BY MODALITY, 2023–2030 (USD MILLION)   146

TABLE 50              ENTERPRISE IMAGING IT MARKET FOR X-RAY, BY REGION,

2023–2030 (USD MILLION)            147

TABLE 51              ENTERPRISE IMAGING IT MARKET FOR MRI, BY REGION,

2023–2030 (USD MILLION)            149

TABLE 52              ENTERPRISE IMAGING IT MARKET FOR CT, BY REGION,

2023–2030 (USD MILLION)            150

TABLE 53              ENTERPRISE IMAGING IT MARKET FOR ULTRASOUND, BY REGION,

2023–2030 (USD MILLION)            151

TABLE 54              ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE,

2023–2030 (USD MILLION)            152

TABLE 55              ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY REGION,

2023–2030 (USD MILLION)            153

TABLE 56              ENTERPRISE IMAGING IT MARKET FOR PET, BY REGION,

2023–2030 (USD MILLION)            154

TABLE 57              ENTERPRISE IMAGING IT MARKET FOR SPECT, BY REGION,

2023–2030 (USD MILLION)            154

TABLE 58              ENTERPRISE IMAGING IT MARKET FOR ENDOSCOPY, BY REGION,

2023–2030 (USD MILLION)            155

TABLE 59              ENTERPRISE IMAGING IT MARKET FOR MAMMOGRAPHY, BY REGION,

2023–2030 (USD MILLION)            156

TABLE 60              ENTERPRISE IMAGING IT MARKET FOR FLUOROSCOPY, BY REGION,

2023–2030 (USD MILLION)            158

TABLE 61              ENTERPRISE IMAGING IT MARKET FOR ECHOCARDIOGRAPHY, BY REGION,

2023–2030 (USD MILLION)            159

TABLE 62              ENTERPRISE IMAGING IT MARKET FOR OTHER MODALITIES, BY REGION,

2023–2030 (USD MILLION)            160

TABLE 63              ENTERPRISE IMAGING IT MARKET, BY OFFERING, 2023–2030 (USD MILLION)     162

TABLE 64              ENTERPRISE IMAGING IT MARKET FOR SOFTWARE, BY REGION,

2023–2030 (USD MILLION)            163

TABLE 65              ENTERPRISE IMAGING IT MARKET FOR SERVICES, BY REGION,

2023–2030 (USD MILLION)            164

TABLE 66              ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,

2023–2030 (USD MILLION)            166

TABLE 67              ENTERPRISE IMAGING IT MARKET FOR ON-PREMISES SOLUTIONS, BY REGION, 2023–2030 (USD MILLION)                 167

TABLE 68              ENTERPRISE IMAGING IT MARKET FOR CLOUD-BASED SOLUTIONS, BY REGION, 2023–2030 (USD MILLION)                 168

TABLE 69              ENTERPRISE IMAGING IT MARKET FOR HYBRID SOLUTIONS, BY REGION,

2023–2030 (USD MILLION)            169

TABLE 70              ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,

2023–2030 (USD MILLION)            171

TABLE 71              ENTERPRISE IMAGING IT MARKET FOR NEUROLOGY, BY REGION,

2023–2030 (USD MILLION)            172

TABLE 72              ENTERPRISE IMAGING IT MARKET FOR CARDIOLOGY, BY REGION,

2023–2030 (USD MILLION)            173

TABLE 73              ENTERPRISE IMAGING IT MARKET FOR ONCOLOGY, BY REGION,

2023–2030 (USD MILLION)            175

TABLE 74              ENTERPRISE IMAGING IT MARKET FOR ORTHOPEDICS, BY REGION,

2023–2030 (USD MILLION)            176

TABLE 75              ENTERPRISE IMAGING IT MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2023–2030 (USD MILLION)                 176

TABLE 76              ENTERPRISE IMAGING IT MARKET, FOR END USER, 2023–2030 (USD MILLION)                178

TABLE 77              ENTERPRISE IMAGING IT MARKET FOR HOSPITALS, BY REGION,

2023–2030 (USD MILLION)            179

TABLE 78              ENTERPRISE IMAGING IT MARKET FOR DIAGNOSTIC CENTERS, BY REGION,

2023–2030 (USD MILLION)            180

TABLE 79              ENTERPRISE IMAGING IT MARKET FOR CLINICS & OUTPATIENT SETTINGS,

BY REGION, 2023–2030 (USD MILLION)   181

TABLE 80              ENTERPRISE IMAGING IT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)          182

TABLE 81              ENTERPRISE IMAGING IT MARKET FOR MEDTECH COMPANIES, BY REGION,

2023–2030 (USD MILLION)            183

TABLE 82              ENTERPRISE IMAGING IT MARKET FOR RESEARCH & ACADEMIC INSTITUTES,

BY REGION, 2023–2030 (USD MILLION)   185

TABLE 83              ENTERPRISE IMAGING IT MARKET FOR OTHER END USERS, BY REGION,

2023–2030 (USD MILLION)            186

TABLE 84              ENTERPRISE IMAGING IT MARKET, BY REGION, 2023–2030 (USD MILLION)            188

TABLE 85              NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            190

TABLE 86              NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            190

TABLE 87              NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY MODALITY,

2023–2030 (USD MILLION)            191

TABLE 88              NORTH AMERICA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,

BY TYPE, 2023–2030 (USD MILLION)         191

TABLE 89              NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            192

TABLE 90              NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY OFFERING,

2023–2030 (USD MILLION)            192

TABLE 91              NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)                 192

TABLE 92              NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)                 193

TABLE 93              NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY END USER,

2023–2030 (USD MILLION)            193

TABLE 94              US: KEY MACROINDICATORS     195

TABLE 95              US: ENTERPRISE IMAGING IT MARKET, BY FUNCTION, 2023–2030 (USD MILLION)   195

TABLE 96              US: ENTERPRISE IMAGING IT MARKET, BY MODALITY, 2023–2030 (USD MILLION)   196

TABLE 97              US: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE,

2023–2030 (USD MILLION)            196

TABLE 98              US: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            197

TABLE 99              US: ENTERPRISE IMAGING IT MARKET, BY OFFERING, 2023–2030 (USD MILLION)     197

TABLE 100            US: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,

2023–2030 (USD MILLION)            197

TABLE 101            US: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,

2023–2030 (USD MILLION)            198

TABLE 102            US: ENTERPRISE IMAGING IT MARKET, BY END USER, 2023–2030 (USD MILLION)                198

TABLE 103            CANADA: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            200

TABLE 104            CANADA: ENTERPRISE IMAGING IT MARKET, BY MODALITY,

2023–2030 (USD MILLION)            200

TABLE 105            CANADA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE, 2023–2030 (USD MILLION)                 201

TABLE 106            CANADA: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            201

TABLE 107            CANADA: ENTERPRISE IMAGING IT MARKET, BY OFFERING,

2023–2030 (USD MILLION)            201

TABLE 108            CANADA: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,

2023–2030 (USD MILLION)            202

TABLE 109            CANADA: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,

2023–2030 (USD MILLION)            202

TABLE 110            CANADA: ENTERPRISE IMAGING IT MARKET, BY END USER,

2023–2030 (USD MILLION)            203

TABLE 111            EUROPE: ENTERPRISE IMAGING IT MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            204

TABLE 112            EUROPE: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            204

TABLE 113            EUROPE: ENTERPRISE IMAGING IT MARKET, BY MODALITY,

2023–2030 (USD MILLION)            205

TABLE 114            EUROPE: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,

BY TYPE, 2023–2030 (USD MILLION)         205

TABLE 115            EUROPE: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            206

TABLE 116            EUROPE: ENTERPRISE IMAGING IT MARKET, BY OFFERING,

2023–2030 (USD MILLION)            206

TABLE 117            EUROPE: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,

2023–2030 (USD MILLION)            206

TABLE 118            EUROPE: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,

2023–2030 (USD MILLION)            207

TABLE 119            EUROPE: ENTERPRISE IMAGING IT MARKET, BY END USER,

2023–2030 (USD MILLION)            207

TABLE 120            GERMANY: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            209

TABLE 121            GERMANY: ENTERPRISE IMAGING IT MARKET, BY MODALITY,

2023–2030 (USD MILLION)            209

TABLE 122            GERMANY: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,

BY TYPE, 2023–2030 (USD MILLION)         210

TABLE 123            GERMANY: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            210

TABLE 124            GERMANY: ENTERPRISE IMAGING IT MARKET, BY OFFERING,

2023–2030 (USD MILLION)            210

TABLE 125            GERMANY: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,

2023–2030 (USD MILLION)            211

TABLE 126            GERMANY: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,

2023–2030 (USD MILLION)            211

TABLE 127            GERMANY: ENTERPRISE IMAGING IT MARKET, BY END USER,

2023–2030 (USD MILLION)            212

TABLE 128            UK: ENTERPRISE IMAGING IT MARKET, BY FUNCTION, 2023–2030 (USD MILLION)   213

TABLE 129            UK: ENTERPRISE IMAGING IT MARKET, BY MODALITY, 2023–2030 (USD MILLION)   213

TABLE 130            UK: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE,

2023–2030 (USD MILLION)            214

TABLE 131            UK: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            214

TABLE 132            UK: ENTERPRISE IMAGING IT MARKET, BY OFFERING, 2023–2030 (USD MILLION)     214

TABLE 133            UK: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,

2023–2030 (USD MILLION)            215

TABLE 134            UK: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,

2023–2030 (USD MILLION)            215

TABLE 135            UK: ENTERPRISE IMAGING IT MARKET, BY END USER, 2023–2030 (USD MILLION)                216

TABLE 136            FRANCE: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            217

TABLE 137            FRANCE: ENTERPRISE IMAGING IT MARKET, BY MODALITY,

2023–2030 (USD MILLION)            217

TABLE 138            FRANCE: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE, 2023–2030 (USD MILLION)                 218

TABLE 139            FRANCE: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            218

TABLE 140            FRANCE: ENTERPRISE IMAGING IT MARKET, BY OFFERING,

2023–2030 (USD MILLION)            218

TABLE 141            FRANCE: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,

2023–2030 (USD MILLION)            219

TABLE 142            FRANCE: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,

2023–2030 (USD MILLION)            219

TABLE 143            FRANCE: ENTERPRISE IMAGING IT MARKET, BY END USER,

2023–2030 (USD MILLION)            220

TABLE 144            ITALY: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            221

TABLE 145            ITALY: ENTERPRISE IMAGING IT MARKET, BY MODALITY,

2023–2030 (USD MILLION)            221

TABLE 146            ITALY: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE,

2023–2030 (USD MILLION)            222

TABLE 147            ITALY: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,

2023–2030 (USD MILLION)          222

TABLE 148            ITALY: ENTERPRISE IMAGING IT MARKET, BY OFFERING,

2023–2030 (USD MILLION)            222

TABLE 149            ITALY: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,

2023–2030 (USD MILLION)            223

TABLE 150            ITALY: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,

2023–2030 (USD MILLION)            223

TABLE 151            ITALY: ENTERPRISE IMAGING IT MARKET, BY END USER,

2023–2030 (USD MILLION)            224

TABLE 152            SPAIN: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            225

TABLE 153            SPAIN: ENTERPRISE IMAGING IT MARKET, BY MODALITY,

2023–2030 (USD MILLION)            225

TABLE 154            SPAIN: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,

BY TYPE, 2023–2030 (USD MILLION)         226

TABLE 155            SPAIN: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            226

TABLE 156            SPAIN: ENTERPRISE IMAGING IT MARKET, BY OFFERING,

2023–2030 (USD MILLION)            226

TABLE 157            SPAIN: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,

2023–2030 (USD MILLION)            227

TABLE 158            SPAIN: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,

2023–2030 (USD MILLION)            227

TABLE 159            SPAIN: ENTERPRISE IMAGING IT MARKET, BY END USER,

2023–2030 (USD MILLION)            228

TABLE 160            REST OF EUROPE: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            229

TABLE 161            REST OF EUROPE: ENTERPRISE IMAGING IT MARKET, BY MODALITY,

2023–2030 (USD MILLION)            229

TABLE 162            REST OF EUROPE: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,

BY TYPE, 2023–2030 (USD MILLION)         230

TABLE 163            REST OF EUROPE: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            230

TABLE 164            REST OF EUROPE: ENTERPRISE IMAGING IT MARKET, BY OFFERING,

2023–2030 (USD MILLION)            230

TABLE 165            REST OF EUROPE: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)                 231

TABLE 166            REST OF EUROPE: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)                 231

TABLE 167            REST OF EUROPE: ENTERPRISE IMAGING IT MARKET, BY END USER,

2023–2030 (USD MILLION)            232

TABLE 168            ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            235

TABLE 169            ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            235

TABLE 170            ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY MODALITY,

2023–2030 (USD MILLION)          236

TABLE 171            ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE, 2023–2030 (USD MILLION)            236

TABLE 172            ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            237

TABLE 173            ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY OFFERING,

2023–2030 (USD MILLION)            237

TABLE 174            ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,

2023–2030 (USD MILLION)            237

TABLE 175            ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,

2023–2030 (USD MILLION)            238

TABLE 176            ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY END USER,

2023–2030 (USD MILLION)            238

TABLE 177            CHINA: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            239

TABLE 178            CHINA: ENTERPRISE IMAGING IT MARKET, BY MODALITY,

2023–2030 (USD MILLION)            240

TABLE 179            CHINA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE, 2023–2030 (USD MILLION)                 240

TABLE 180            CHINA: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            241

TABLE 181            CHINA: ENTERPRISE IMAGING IT MARKET, BY OFFERING,

2023–2030 (USD MILLION)            241

TABLE 182            CHINA: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,

2023–2030 (USD MILLION)            241

TABLE 183            CHINA: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,

2023–2030 (USD MILLION)            242

TABLE 184            CHINA: ENTERPRISE IMAGING IT MARKET, BY END USER,

2023–2030 (USD MILLION)            242

TABLE 185            JAPAN: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            244

TABLE 186            JAPAN: ENTERPRISE IMAGING IT MARKET, BY MODALITY,

2023–2030 (USD MILLION)            244

TABLE 187            JAPAN: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE, 2023–2030 (USD MILLION)                 245

TABLE 188            JAPAN: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            245

TABLE 189            JAPAN: ENTERPRISE IMAGING IT MARKET, BY OFFERING,

2023–2030 (USD MILLION)            245

TABLE 190            JAPAN: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,

2023–2030 (USD MILLION)            246

TABLE 191            JAPAN: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,

2023–2030 (USD MILLION)            246

TABLE 192            JAPAN: ENTERPRISE IMAGING IT MARKET, BY END USER,

2023–2030 (USD MILLION)            247

TABLE 193            INDIA: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            248

TABLE 194            INDIA: ENTERPRISE IMAGING IT MARKET, BY MODALITY,

2023–2030 (USD MILLION)            248

TABLE 195            INDIA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE,

2023–2030 (USD MILLION)            249

TABLE 196            INDIA: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            249

TABLE 197            INDIA: ENTERPRISE IMAGING IT MARKET, BY OFFERING,

2023–2030 (USD MILLION)            249

TABLE 198            INDIA: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,

2023–2030 (USD MILLION)            250

TABLE 199            INDIA: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,

2023–2030 (USD MILLION)            250

TABLE 200            INDIA: ENTERPRISE IMAGING IT MARKET, BY END USER,

2023–2030 (USD MILLION)            251

TABLE 201            REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            252

TABLE 202            REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY MODALITY,

2023–2030 (USD MILLION)            252

TABLE 203            REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE, 2023–2030 (USD MILLION)            253

TABLE 204            REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            253

TABLE 205            REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY OFFERING,

2023–2030 (USD MILLION)            253

TABLE 206            REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)                 254

TABLE 207            REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)                 254

TABLE 208            REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY END USER,

2023–2030 (USD MILLION)            255

TABLE 209            LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            256

TABLE 210            LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            256

TABLE 211            LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY MODALITY,

2023–2030 (USD MILLION)            257

TABLE 212            LATIN AMERICA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,

BY TYPE, 2023–2030 (USD MILLION)         257

TABLE 213            LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            258

TABLE 214            LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY OFFERING,

2023–2030 (USD MILLION)            258

TABLE 215            LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)                 258

TABLE 216            LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,

2023–2030 (USD MILLION)            259

TABLE 217            LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY END USER,

2023–2030 (USD MILLION)            259

TABLE 218            BRAZIL: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            260

TABLE 219            BRAZIL: ENTERPRISE IMAGING IT MARKET, BY MODALITY,

2023–2030 (USD MILLION)            261

TABLE 220            BRAZIL: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,

BY TYPE, 2023–2030 (USD MILLION)         261

TABLE 221            BRAZIL: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,

2023–2030 (USD MILLION)          262

TABLE 222            BRAZIL: ENTERPRISE IMAGING IT MARKET, BY OFFERING,

2023–2030 (USD MILLION)            262

TABLE 223            BRAZIL: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,

2023–2030 (USD MILLION)            262

TABLE 224            BRAZIL: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,

2023–2030 (USD MILLION)          263

TABLE 225            BRAZIL: ENTERPRISE IMAGING IT MARKET, BY END USER,

2023–2030 (USD MILLION)            263

TABLE 226            MEXICO: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            265

TABLE 227            MEXICO: ENTERPRISE IMAGING IT MARKET, BY MODALITY,

2023–2030 (USD MILLION)            265

TABLE 228            MEXICO: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE, 2023–2030 (USD MILLION)                 266

TABLE 229            MEXICO: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            266

TABLE 230            MEXICO: ENTERPRISE IMAGING IT MARKET, BY OFFERING,

2023–2030 (USD MILLION)            266

TABLE 231            MEXICO: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,

2023–2030 (USD MILLION)            267

TABLE 232            MEXICO: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,

2023–2030 (USD MILLION)            267

TABLE 233            MEXICO: ENTERPRISE IMAGING IT MARKET, BY END USER,

2023–2030 (USD MILLION)            268

TABLE 234            REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            269

TABLE 235            REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY MODALITY,

2023–2030 (USD MILLION)            269

TABLE 236            REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE, 2023–2030 (USD MILLION)       270

TABLE 237            REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            270

TABLE 238            REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY OFFERING,

2023–2030 (USD MILLION)            270

TABLE 239            REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)            271

TABLE 240            REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)            271

TABLE 241            REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY END USER,

2023–2030 (USD MILLION)            272

TABLE 242            MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET, BY REGION,

2023–2030 (USD MILLION)            273

TABLE 243            MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            274

TABLE 244            MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET, BY MODALITY,

2023–2030 (USD MILLION)            274

TABLE 245            MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE, 2023–2030 (USD MILLION)            275

TABLE 246            MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET, BY APPLICATION, 2023–2030 (USD MILLION)                 275

TABLE 247            MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET, BY OFFERING,

2023–2030 (USD MILLION)            275

TABLE 248            MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)                 276

TABLE 249            MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)                 276

TABLE 250            MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET, BY END USER,

2023–2030 (USD MILLION)            277

TABLE 251            GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            278

TABLE 252            GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET, BY MODALITY,

2023–2030 (USD MILLION)            279

TABLE 253            GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,

BY TYPE, 2023–2030 (USD MILLION)         279

TABLE 254            GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            280

TABLE 255            GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET, BY OFFERING,

2023–2030 (USD MILLION)            280

TABLE 256            GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)                 280

TABLE 257            GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)                 281

TABLE 258            GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET, BY END USER,

2023–2030 (USD MILLION)            281

TABLE 259            REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,

BY FUNCTION, 2023–2030 (USD MILLION)             282

TABLE 260            REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,

BY MODALITY, 2023–2030 (USD MILLION)             283

TABLE 261            REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE, 2023–2030 (USD MILLION)       283

TABLE 262            REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,

BY APPLICATION, 2023–2030 (USD MILLION)       284

TABLE 263            REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,

BY OFFERING, 2023–2030 (USD MILLION)               284

TABLE 264            REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,

BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)        284

TABLE 265            REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,

BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)          285

TABLE 266            REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,

BY END USER, 2023–2030 (USD MILLION)               285

TABLE 267            OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ENTERPRISE IMAGING IT MARKET, JANUARY 2022–JUNE 2025             287

TABLE 268            ENTERPRISE IMAGING IT MARKET: DEGREE OF COMPETITION 292

TABLE 269            ENTERPRISE IMAGING IT MARKET: REGION FOOTPRINT       296

TABLE 270            ENTERPRISE IMAGING IT MARKET: FUNCTION FOOTPRINT       297

TABLE 271            ENTERPRISE IMAGING IT MARKET: APPLICATION FOOTPRINT         298

TABLE 272            ENTERPRISE IMAGING IT MARKET: THERAPEUTIC AREA FOOTPRINT            299

TABLE 273            ENTERPRISE IMAGING IT MARKET: DEPLOYMENT MODE FOOTPRINT          300

TABLE 274            ENTERPRISE IMAGING IT MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS     303

TABLE 275            ENTERPRISE IMAGING IT MARKET: COMPETITIVE BENCHMARKING OF

KEY EMERGING PLAYERS/STARTUPS, BY REGION            303

TABLE 276            ENTERPRISE IMAGING IT MARKET: COMPETITIVE BENCHMARKING

OF KEY EMERGING PLAYERS/STARTUPS, BY FUNCTION                 304

TABLE 277            ENTERPRISE IMAGING IT MARKET: COMPETITIVE BENCHMARKING

OF KEY EMERGING PLAYERS/STARTUPS, BY THERAPEUTIC AREA     304

TABLE 278            ENTERPRISE IMAGING IT MARKET: SOLUTION LAUNCHES, APPROVALS, AND ENHANCEMENTS, JANUARY 2022–JUNE 2025             307

TABLE 279            ENTERPRISE IMAGING IT MARKET: DEALS, JANUARY 2022–JUNE 2025              308

TABLE 280            ENTERPRISE IMAGING IT MARKET: EXPANSIONS, JANUARY 2022–JUNE 2025 309

TABLE 281            AGFA-GEVAERT GROUP: COMPANY OVERVIEW                 310

TABLE 282            AGFA-GEVAERT GROUP: SOLUTIONS OFFERED                 311

TABLE 283            AGFA-GEVAERT GROUP: DEALS, JANUARY 2022–JUNE 2025             313

TABLE 284            FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW   315

TABLE 285            FUJIFILM HOLDINGS CORPORATION: SOLUTIONS OFFERED   317

TABLE 286            FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2022–JUNE 2025              318

TABLE 287            GE HEALTHCARE: COMPANY OVERVIEW                 320

TABLE 288            GE HEALTHCARE: SOLUTIONS OFFERED                 321

TABLE 289            GE HEALTHCARE: SOLUTION LAUNCHES & APPROVALS,

JANUARY 2022–JUNE 2025              322

TABLE 290            GE HEALTHCARE: DEALS, JANUARY 2022–JUNE 2025        323

TABLE 291            KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW          325

TABLE 292            KONINKLIJKE PHILIPS N.V.: SOLUTIONS OFFERED             326

TABLE 293            KONINKLIJKE PHILIPS N.V.: SOLUTION LAUNCHES & APPROVALS,

JANUARY 2022–JUNE 2025              328

TABLE 294            KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2022–JUNE 2025  329

TABLE 295            KONINKLIJKE PHILIPS N.V.: EXPANSIONS, JANUARY 2022–JUNE 2025              329

TABLE 296            SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW          331

TABLE 297            SIEMENS HEALTHINEERS AG: SOLUTIONS OFFERED             332

TABLE 298            SIEMENS HEALTHINEERS AG: SOLUTION LAUNCHES, JANUARY 2022–JUNE 2025     335

TABLE 299            SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2022–JUNE 2025  335

TABLE 300            OPTUM, INC.: COMPANY OVERVIEW      337

TABLE 301            OPTUM, INC.: SOLUTIONS OFFERED      338

TABLE 302            OPTUM, INC.: DEALS, JANUARY 2022–JUNE 2025                 340

TABLE 303            SECTRA AB: COMPANY OVERVIEW          342

TABLE 304            SECTRA AB: SOLUTIONS OFFERED          344

TABLE 305            SECTRA AB: SOLUTION LAUNCHES & APPROVALS, JANUARY 2022–JUNE 2025   346

TABLE 306            SECTRA AB: DEALS, JANUARY 2022–JUNE 2025                 347

TABLE 307            CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW   348

TABLE 308            CANON MEDICAL SYSTEMS CORPORATION: SOLUTIONS OFFERED   350

TABLE 309            CANON MEDICAL SYSTEMS CORPORATION: DEALS, JANUARY 2022–JUNE 2025              351

TABLE 310            CANON MEDICAL SYSTEMS CORPORATION: EXPANSIONS,

JANUARY 2022–JUNE 2025              351

TABLE 311            MERATIVE: COMPANY OVERVIEW           352

TABLE 312            MERATIVE: SOLUTIONS OFFERED           352

TABLE 313            MERATIVE: DEALS, JANUARY 2022–JUNE 2025                 353

TABLE 314            MERATIVE: EXPANSIONS, JANUARY 2022–JUNE 2025        353

TABLE 315            PRO MEDICUS, LTD.: COMPANY OVERVIEW                 354

TABLE 316            PRO MEDICUS, LTD.: SOLUTIONS OFFERED                 356

TABLE 317            PRO MEDICUS, LTD.: SOLUTION LAUNCHES, JANUARY 2022–JUNE 2025              357

TABLE 318            PRO MEDICUS, LTD.: DEALS, JANUARY 2022–JUNE 2025             357

TABLE 319            INTELERAD MEDICAL SYSTEMS INCORPORATED: COMPANY OVERVIEW               358

TABLE 320            INTELERAD MEDICAL SYSTEMS INCORPORATED: SOLUTIONS OFFERED               358

TABLE 321            INTELERAD MEDICAL SYSTEMS INCORPORATED: SOLUTION LAUNCHES,

JANUARY 2022–JUNE 2025              360

TABLE 322            INTELERAD: DEALS, JANUARY 2022–JUNE 2025                 360

TABLE 323            HYLAND SOFTWARE, INC.: COMPANY OVERVIEW          362

TABLE 324            HYLAND SOFTWARE, INC.: SOLUTIONS OFFERED             362

TABLE 325            HYLAND SOFTWARE, INC.: SOLUTION LAUNCHES, JANUARY 2022–JUNE 2025     363

TABLE 326            HYLAND SOFTWARE, INC.: DEALS, JANUARY 2022–JUNE 2025  363

TABLE 327            INFINITT HEALTHCARE CO., LTD.: COMPANY OVERVIEW          365

TABLE 328            INFINITT HEALTHCARE CO., LTD.: SOLUTIONS OFFERED             366

TABLE 329            INFINITT HEALTHCARE CO., LTD.: SOLUTION LAUNCHES & APPROVALS,

JANUARY 2022–JUNE 2025              366

TABLE 330            INFINITT HEALTHCARE CO., LTD.: DEALS, JANUARY 2022–JUNE 2025              367

TABLE 331            NOVARAD: COMPANY OVERVIEW            368

TABLE 332            NOVARAD: SOLUTIONS OFFERED            368

TABLE 333            MACH7 TECHNOLOGIES: COMPANY OVERVIEW                 370

TABLE 334            MACH7 TECHNOLOGIES: SOLUTIONS OFFERED                 372

TABLE 335            MACH7 TECHNOLOGIES: SOLUTION LAUNCHES, JANUARY 2022–JUNE 2025     373

TABLE 336            MACH7 TECHNOLOGIES: DEALS, JANUARY 2022–JUNE 2025  373

TABLE 337            HERMES MEDICAL SOLUTIONS: COMPANY OVERVIEW          374

TABLE 338            HERMES MEDICAL SOLUTIONS: SOLUTIONS OFFERED             374

TABLE 339            HERMES MEDICAL SOLUTIONS: SOLUTION LAUNCHES, APPROVALS, AND ENHANCEMENTS, JANUARY 2022–JUNE 2025             376

TABLE 340            HERMES MEDICAL SOLUTIONS: DEALS, JANUARY 2022–JUNE 2025              377

TABLE 341            KONICA MINOLTA, INC.: COMPANY OVERVIEW                 378

TABLE 342            KONICA MINOLTA, INC.: SOLUTIONS OFFERED                 379

TABLE 343            KONICA MINOLTA, INC.: SOLUTION LAUNCHES & ENHANCEMENTS,

JANUARY 2022–JUNE 2025              381

TABLE 344            KONICA MINOLTA, INC.: DEALS, JANUARY 2022–JUNE 2025             381

TABLE 345            BRIDGEHEAD SOFTWARE LTD.: COMPANY OVERVIEW          383

TABLE 346            BRIDGEHEAD SOFTWARE LTD.: SOLUTIONS OFFERED             383

TABLE 347            BRIDGEHEAD SOFTWARE LTD.: DEALS, JANUARY 2022–JUNE 2025              384

TABLE 348            SCIMAGE, INC.: COMPANY OVERVIEW   385

TABLE 349            SCIMAGE, INC.: SOLUTIONS OFFERED   385

TABLE 350            SCIMAGE, INC.: SOLUTION LAUNCHES, JANUARY 2022–JUNE 2025              386

TABLE 351            SCIMAGE, INC.: DEALS, JANUARY 2022–JUNE 2025        387

TABLE 352            VISUS HEALTH IT GMBH: COMPANY OVERVIEW                 388

TABLE 353            VISUS HEALTH IT GMBH: SOLUTIONS OFFERED                 388

TABLE 354            VISUS HEALTH IT GMBH: SOLUTION ENHANCEMENTS, JANUARY 2022–JUNE 2025        389

LIST OF FIGURES

FIGURE 1              ENTERPRISE IMAGING IT MARKET SEGMENTATION & REGIONAL SCOPE    34

FIGURE 2              RESEARCH DESIGN         39

FIGURE 3              PRIMARY SOURCES         41

FIGURE 4              INSIGHTS FROM INDUSTRY EXPERTS     43

FIGURE 5              BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION  43

FIGURE 6              RESEARCH METHODOLOGY: HYPOTHESIS BUILDING           44

FIGURE 7              SUPPLY-SIDE MARKET ESTIMATION      46

FIGURE 8              ENTERPRISE IMAGING IT MARKET: REVENUE ESTIMATION APPROACH              46

FIGURE 9              BOTTOM-UP APPROACH: END-USER SPENDING ON ENTERPRISE IMAGING IT     48

FIGURE 10            CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2025–2030)          50

FIGURE 11            CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS                 51

FIGURE 12            TOP-DOWN APPROACH                51

FIGURE 13            DATA TRIANGULATION METHODOLOGY                 52

FIGURE 14            ENTERPRISE IMAGING IT MARKET, BY FUNCTION, 2025 VS. 2030 (USD MILLION)             55

FIGURE 15            ENTERPRISE IMAGING IT MARKET, BY MODALITY, 2025 VS. 2030 (USD MILLION)             56

FIGURE 16            ENTERPRISE IMAGING IT MARKET, BY APPLICATION,

2025 VS. 2030 (USD MILLION)      57

FIGURE 17            ENTERPRISE IMAGING IT MARKET, BY OFFERING, 2025 VS. 2030 (USD MILLION)               57

FIGURE 18            ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,

2025 VS. 2030 (USD MILLION)      58

FIGURE 19            ENTERPRISE IMAGING IT MARKET: GEOGRAPHICAL SNAPSHOT       59

FIGURE 20            RISING IMAGING VOLUMES TO DRIVE GROWTH IN ENTERPRISE IMAGING IT MARKET    60

FIGURE 21            DIAGNOSTIC APPLICATIONS IN NORTH AMERICA ACCOUNTED FOR

LARGEST MARKET SHARE IN 2024             61

FIGURE 22            INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD       62

FIGURE 23            GROWTH RATES OF EMERGING ECONOMIES TO BE HIGHER THAN THOSE OF DEVELOPED MARKETS DURING FORECAST PERIOD       63

FIGURE 24            ENTERPRISE IMAGING IT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES         64

FIGURE 25            HEALTHCARE SECURITY BREACHES OF 500+ RECORDS IN US, 2009–2024           69

FIGURE 26            US: MEDIAN HEALTHCARE DATA BREACH SIZE BY YEAR, 2009–2024          70

FIGURE 27            INDIVIDUALS AFFECTED BY HEALTHCARE SECURITY BREACHES IN US, 2009–2023   70

FIGURE 28            TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES           78

FIGURE 29            ENTERPRISE IMAGING IT MARKET: ECOSYSTEM ANALYSIS            81

FIGURE 30            ENTERPRISE IMAGING IT MARKET: SUPPLY CHAIN ANALYSIS (2024) 84

FIGURE 31            ENTERPRISE IMAGING IT MARKET: PORTER’S FIVE FORCES ANALYSIS 101

FIGURE 32            PATENT PUBLICATION TRENDS IN ENTERPRISE IMAGING IT MARKET, 2015–2025                103

FIGURE 33            JURISDICTION AND TOP APPLICANT ANALYSIS FOR ENTERPRISE

IMAGING IT MARKET     104

FIGURE 34            TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR ENTERPRISE IMAGING IT MARKET (JANUARY 2015 TO JULY 2025) 105

FIGURE 35            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS            107

FIGURE 36            KEY BUYING CRITERIA FOR TOP THREE END USERS   108

FIGURE 38            MARKET POTENTIAL OF AI/GENERATIVE AI IN ENHANCING ENTERPRISE

IMAGING IT ACROSS INDUSTRIES            117

FIGURE 39            IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS   120

FIGURE 40            NORTH AMERICA: ENTERPRISE IMAGING IT MARKET SNAPSHOT       189

FIGURE 41            ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET SNAPSHOT       234

FIGURE 42            REVENUE ANALYSIS OF KEY PLAYERS IN ENTERPRISE IMAGING IT MARKET,

2020–2024 (USD MILLION)            290

FIGURE 43            MARKET SHARE ANALYSIS OF KEY PLAYERS IN ENTERPRISE IMAGING

IT MARKET (2024)             291

FIGURE 44            ENTERPRISE IMAGING IT MARKET: COMPANY EVALUATION MATRIX

(KEY PLAYERS), 2024       294

FIGURE 45            ENTERPRISE IMAGING IT MARKET: COMPANY FOOTPRINT       295

FIGURE 46            ENTERPRISE IMAGING IT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 302

FIGURE 47            EV/EBITDA OF KEY VENDORS   305

FIGURE 48            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK

BETA OF KEY VENDORS                305

FIGURE 49            ENTERPRISE IMAGING IT MARKET: BRAND/SOFTWARE COMPARITIVE ANALYSIS     306

FIGURE 50            AGFA-GEVAERT GROUP: COMPANY SNAPSHOT (2024)    311

FIGURE 51            FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2023)      316

FIGURE 52            GE HEALTHCARE: COMPANY SNAPSHOT (2024)                 321

FIGURE 53            KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2024)             326

FIGURE 54            SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2024)             332

FIGURE 55            OPTUM, INC.: COMPANY SNAPSHOT (2024)                 338

FIGURE 56            SECTRA AB: COMPANY SNAPSHOT (2023)                 343

FIGURE 57            CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT (2024)      349

FIGURE 58            PRO MEDICUS, LTD.: COMPANY SNAPSHOT (2024)    355

FIGURE 59            INFINITT HEALTHCARE CO., LTD.: COMPANY SNAPSHOT (2024)             365

FIGURE 60            MACH7 TECHNOLOGIES: COMPANY SNAPSHOT (2023)    371

FIGURE 61            KONICA MINOLTA, INC.: COMPANY SNAPSHOT (2024)    379

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧